君实生物：关于JT118获得药物临床试验批准通知书的公告

Group 1 - The core point of the article is that Junshi Biosciences announced the approval of a clinical trial application for its drug JT118 injection by the National Medical Products Administration [1] Group 2 - The approval was granted to Junshi's subsidiary, Shanghai Juntao Biopharmaceutical Technology Co., Ltd [1] - The announcement was made on the evening of September 2 [1]